LH vs MEDP: fair value comparison
Labcorp Holdings Inc. and Medpace Holdings, Inc. · Updated 2026-09-06
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, MEDP currently sits closer to the top of our discount ranking.
| LH | MEDP | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $326.89 | $573.29 |
| 12-month range | $251.66–$327.61 | $417.54–$594.02 |
| Sector rank | #91 of 113 Healthcare | #89 of 113 Healthcare |
| Quality grade | C | C |
| Leverage | Moderate | Low |
| Margin trend | Stable | — |
| Revenue growth | Modest | — |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Mixed |
| DCF cross-check | Overvalued | — |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: LH fair value analysis · MEDP fair value analysis